1. Journal policies on authorship and contributorship: This is described in the section titled ‘Publication ethics.’

2. How the journal will handle complaints and appeals;

2.1. The policy of the journal is primarily aimed at protecting the authors, reviewers, editors, and the publisher of the journal. If not described below, the process of handling complaints and appeals follows the guidelines of the Committee of Publication Ethics available from: https://publicationethics. org/appeals

2.2. Who Could Complain or Make an Appeal? Submitters, authors, reviewers, and readers may register complaints and appeals in a variety of cases as follows: falsification, fabrication, plagiarism, duplicate publication, authorship dispute, conflict of interest, ethical treatment of animals, informed consent, bias or unfair/inappropriate competitive acts, copyright, stolen data, defamation, and legal problem. If any individuals or institutions want to inform JDTREA of such cases, they can send a letter to editor detailing their complaints or appeals. Concrete data with answers to all factual questions (who, when, where, what, how, & why) should be provided.

2.3. Who is responsible to resolve and handle complaints and appeals? The Editor, Editorial Board, and Editorial Office are responsible.

2.4 .What may be the consequence or remedy? It depends on the type or degree of misconduct. The consequences and resolutions will follow the guidelines of the Committee of Publication Ethics (COPE).

3. Journal policies on conflicts of interest/competing interests: This is described in the section titled, ‘Instructions to Authors.’

4. Journal policies on data sharing and reproducibility; Open data policy:

For clarifications on result accuracy and reproducibility of the results, raw data or analysis data will be deposited to a public repository after acceptance of the manuscript. Therefore, submission of the raw data or analysis data is mandatory. If the data is already a public one, its URL site or sources should be disclosed. If data cannot be publicized, it can be negotiated with the editor. If there are any inquiries on depositing data or receiving a data sharing waiver, authors should contact the editorial office.

If the data sharing plan changes after registration, this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. All of the authors of research articles that deal with interventional clinical trials must submit a data sharing plan. Based on the degree of the sharing plan, authors should deposit their data after deidentification and report the DOI of the data and the registered site.

5. Journal's policy on ethical oversight:

When the journal faces suspected cases of research and publication misconduct such as a redundant (duplicate) publication, plagiarism, fabricated data, changes in authorship, undisclosed conflicts of interest, an ethical problem discovered with the submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and other issues, the resolving process will follow the flowchart provided by the Committee on Publication Ethics (http://publica- tionethics.org/resources/flowcharts). The Editorial Board will discuss the suspected cases and reach a decision. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

6. The journal's policy on intellectual property:

All published papers become the permanent property of the Daesoon Academy of Sciences. Copyrights of all published materials are owned by the Daesoon Academy of Sciences.

7. The journal's options for post-publication discussions and corrections: Post-publication discussion is available by sending a letter to editor. If any readers have a concern on any articles published, they can submit s letter to the editor regarding the articles. If any errors or mistakes are found in the article, it can be corrected through errata, corrigenda, or retraction.